Clinical Trial Update: Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol for aromatase inhibitor-associated arthralgia in breast cancer patients has completed, with results posted on 2025…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Arthralgia, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-05-09